Complexities Surrounding N-1-Methylpseudouridine (M1ψ) in COVID-19 Synthetic Gene Therapies
To the Editor:
N-1-methylpseudouridine (m1Ψ) was introduced into modified-mRNA vaccines to reduce immunogenicity and increase mRNA stability, but its presence can indeed affect translation in several ways.
Enjoying this content? Consider making a donation to help us continue to provide quality medical research at no cost.
Share This Article
Author(s): Andrew Zywiec, Abdul Mannan Baig
Published: May 7, 2025
ISSN# 3066-2354
Stay Connected
You'll receive breaking news, updates, and exclusive content.